SIRT2 and hepatocellular carcinoma: Meanwhile, accumulating studies have indicated that elevated expression of SIRT2 was also associated with the progression of gastric cancer (Li et al., 2018), hepatocellular carcinoma, and basal-like breast cancer (Zhou et al., 2016).